BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 11096748)

  • 1. Tardive Dyskinesia.
    Tarsy D
    Curr Treat Options Neurol; 2000 May; 2(3):205-214. PubMed ID: 11096748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevention and treatment of tardive dyskinesia caused by antipsychotic drugs].
    Seigneurie AS; Sauvanaud F; Limosin F
    Encephale; 2016 Jun; 42(3):248-54. PubMed ID: 26922134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of tardive dyskinesia.
    Egan MF; Apud J; Wyatt RJ
    Schizophr Bull; 1997; 23(4):583-609. PubMed ID: 9365997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tardive dyskinesia.
    Aia PG; Revuelta GJ; Cloud LJ; Factor SA
    Curr Treat Options Neurol; 2011 Jun; 13(3):231-41. PubMed ID: 21365202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of tardive dyskinesia: use of dopamine-depleting agents.
    Fahn S
    Clin Neuropharmacol; 1983 Jun; 6(2):151-8. PubMed ID: 6133619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic measures in tardive dyskinesia].
    Tegeler J; Wöller W
    Fortschr Neurol Psychiatr; 1983 Jun; 51(6):203-26. PubMed ID: 6136457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updating the recommendations for treatment of tardive syndromes: A systematic review of new evidence and practical treatment algorithm.
    Bhidayasiri R; Jitkritsadakul O; Friedman JH; Fahn S
    J Neurol Sci; 2018 Jun; 389():67-75. PubMed ID: 29454493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The treatment of tardive dyskinesia and tardive dystonia.
    Simpson GM
    J Clin Psychiatry; 2000; 61 Suppl 4():39-44. PubMed ID: 10739330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of tardive dyskinesia: is risk declining with modern antipsychotics?
    Tarsy D; Baldessarini RJ
    Mov Disord; 2006 May; 21(5):589-98. PubMed ID: 16532448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tardive drug-induced extrapyramidal syndromes.
    Marsálek M
    Pharmacopsychiatry; 2000 Sep; 33 Suppl 1():14-33. PubMed ID: 11072762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of tardive dyskinesia before and during the era of modern antipsychotic drugs.
    Tarsy D; Lungu C; Baldessarini RJ
    Handb Clin Neurol; 2011; 100():601-16. PubMed ID: 21496610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tardive dyskinesia in Asia- current clinical practice and the role of neurologists in the care pathway.
    Bhidayasiri R; Phokaewvarangkul O; Shang HF; Lim TT; Cho JW; Pal PK; Watanabe H
    Front Neurol; 2024; 15():1356761. PubMed ID: 38419696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of tardive dyskinesia and tardive dystonia in African Caribbean patients on long-term antipsychotic treatment: the Curaçao extrapyramidal syndromes study V.
    van Harten PN; Hoek HW; Matroos GE; van Os J
    J Clin Psychiatry; 2006 Dec; 67(12):1920-7. PubMed ID: 17194270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors.
    Niemann N; Jankovic J
    Drugs; 2018 Apr; 78(5):525-541. PubMed ID: 29484607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Forgotten but not gone: new developments in the understanding and treatment of tardive dyskinesia.
    Meyer JM
    CNS Spectr; 2016 Dec; 21(S1):13-24. PubMed ID: 28044943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classification and treatment of tardive syndromes.
    Fernandez HH; Friedman JH
    Neurologist; 2003 Jan; 9(1):16-27. PubMed ID: 12801428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assesment of Risk Factors for Tardive Dyskinesia.
    Vardar MK; Ceylan ME; Ünsalver BÖ
    Psychopharmacol Bull; 2020 Jul; 50(3):36-46. PubMed ID: 32733110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tardive dyskinesia: Who gets it and why.
    Frei K
    Parkinsonism Relat Disord; 2019 Feb; 59():151-154. PubMed ID: 30522959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tardive dyskinesia: current clinical issues.
    Burke RE
    Neurology; 1984 Oct; 34(10):1348-53. PubMed ID: 6148718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
    McGrath JJ; Soares KV
    Cochrane Database Syst Rev; 2000; (2):CD000459. PubMed ID: 10796546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.